Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma

Histopathology

Volumn 62, Issue 1, 2013, Pages 161-175

  Del Pino, Marta ^a   Rodriguez Carunchio, Leonardo ^b   Ordi, Jaume ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

HPV; P16; Prognosis; Vulvar cancer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN E7; PROTEIN P53;

BIOACCUMULATION; CANCER GROWTH; CANCER PROGNOSIS; CELL PROLIFERATION; CHROMOSOME ANALYSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PARAKERATOSIS; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VAGINAL INTRAEPITHELIAL NEOPLASIA; VERRUCA VULGARIS; VERRUCOUS CARCINOMA; VULVA CANCER; VULVAR INTRAEPITHELIAL NEOPLASIA; VULVAR SQUAMOUS CELL CARCINOMA;

ALPHAPAPILLOMAVIRUS; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CONDYLOMATA ACUMINATA; FEMALE; GENE SILENCING; GENES, P53; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; MUTATION; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PROGNOSIS; VULVAR NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84871104861     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12034     Document Type: Review

References (113)

1. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet. Gynecol. 2006; 107; 1018-1022.
2. Norris HJ, Norris HJ, Wilkinson E. Tumors of the cervix, vagina and vulva. In Rosai J, Sobin LH ed. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology, 1992; 179-255.
3. Toki T, Kurman RJ, Park JS, Kessis T, Daniel RW, Shah KV. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int. J. Gynecol. Pathol. 1991; 10; 107-125.
4. Kurman RJ, Toki T, Schiffman MH. Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am. J. Surg. Pathol. 1993; 17; 133-145.
5. Fox H, Wells M. Recent advances in the pathology of the vulva. Histopathology 2003; 42; 209-216.
6. McCluggage WG. Recent developments in vulvovaginal pathology. Histopathology 2009; 54; 156-173.
7. Santos M, Landolfi S, Olivella A et al. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am. J. Surg. Pathol. 2006; 30; 1347-1356.
8. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int. J. Gynecol. Pathol. 2001; 20; 16-30.
9. Wilkinson EJ, Kneale B, Lynch P. Report of the ISSVD Terminology Committee. J. Reprod. Med. 1986; 31; 973-974.
10. Sideri M, Jones RW, Wilkinson EJ et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J. Reprod. Med. 2005; 50; 807-810.
11. Ueda Y, Enomoto T, Kimura T, Yoshino K, Fujita M, Kimura T. Two distinct pathways to development of squamous cell carcinoma of the vulva. J. Skin Cancer 2011; 951250; 7.
12. van de Nieuwenhof HP, Bulten J, Hollema H et al. Differentiated vulvar intraepithelial neoplasia is often found in lesions, previously diagnosed as lichen sclerosus, which have progressed to vulvar squamous cell carcinoma. Mod. Pathol. 2011; 24; 297-305.
13. Aulmann S, Schleibaum J, Penzel R, Schirmacher P, Gebauer G, Sinn HP. Gains of chromosome region 3q26 in intraepithelial neoplasia and invasive squamous cell carcinoma of the vulva are frequent and independent of HPV status. J. Clin. Pathol. 2008; 61; 1034-1037.
14. Leibowitch M, Neill S, Pelisse M, Moyal-Baracco M. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br. J. Obstet. Gynaecol. 1990; 97; 1135-1139.
15. Carli P, Cattaneo A, De MA, Biggeri A, Taddei G, Giannotti B. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur. J. Cancer Prev. 1995; 4; 491-495.
16. Carlson JA, Ambros R, Malfetano J et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum. Pathol. 1998; 29; 932-948.
17. Kokka F, Singh N, Faruqi A, Gibbon K, Rosenthal AN. Is differentiated vulval intraepithelial neoplasia the precursor lesion of human papillomavirus-negative vulval squamous cell carcinoma? Int. J. Gynecol. Cancer 2011; 21; 1297-1305.
18. van de Nieuwenhof HP, van Kempen LC, de Hullu JA et al. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned. Cancer Epidemiol. Biomarkers Prev. 2009; 18; 2061-2067.
19. Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am. J. Surg. Pathol. 2006; 30; 310-318.
20. Alonso I, Fuste V, del Pino M et al. Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma? Gynecol. Oncol. 2011; 122; 509-514.
21. Riethdorf S, Neffen EF, Cviko A, Loning T, Crum CP, Riethdorf L. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias. Hum. Pathol. 2004; 35; 1477-1483.
22. Pinto AP, Lin MC, Sheets EE, Muto MG, Sun D, Crum CP. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva. Gynecol. Oncol. 2000; 77; 171-176.
23. Carter JJ, Madeleine MM, Shera K et al. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res. 2001; 61; 1934-1940.
24. Gargano JW, Wilkinson EJ, Unger ER et al. Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J. Low. Genit. Tract. Dis. 2012; 16; 471-479.
25. Tsimplaki E, Argyri E, Michala L et al. Human papillomavirus genotyping and e6/e7 mRNA expression in Greek women with intraepithelial neoplasia and squamous cell carcinoma of the vagina and vulva. J. Oncol. 2012; 893275; 7.
26. Monk BJ, Burger RA, Lin F, Parham G, Vasilev SA, Wilczynski SP. Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet. Gynecol. 1995; 85 (5 Pt 1; 709-715.
27. Kim YT, Thomas NF, Kessis TD, Wilkinson EJ, Hedrick L, Cho KR. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas. Hum. Pathol. 1996; 27; 389-395.
28. Kowalewska M, Szkoda MT, Radziszewski J, Ptaszynski K, Bidzinski M, Siedlecki JA. The frequency of human papillomavirus infection in Polish patients with vulvar squamous cell carcinoma. Int. J. Gynecol. Cancer 2010; 20; 434-437.
29. Garland SM, Hernandez-Avila M, Wheeler CM et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 2007; 356; 1928-1943.
30. Trimble CL, Hildesheim A, Brinton LA, Shah KV, Kurman RJ. Heterogeneous etiology of squamous carcinoma of the vulva. Obstet. Gynecol. 1996; 87; 59-64.
31. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet. Gynecol. 2009; 113; 917-924.
32. Bonvicini F, Venturoli S, Ambretti S et al. Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma. J. Med. Virol. 2005; 77; 102-106.
33. Pinto AP, Lin MC, Mutter GL, Sun D, Villa LL, Crum CP. Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas. Am. J. Pathol. 1999; 154; 1009-1015.
34. van der Avoort I, Shirango H, Hoevenaars BM et al. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int. J. Gynecol. Pathol. 2006; 25; 22-29.
35. Kenter GG, Welters MJ, Valentijn AR et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N. Engl. J. Med. 2009; 361; 1838-1847.
36. Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction. Obstet. Gynecol. 1997; 89; 81-84.
37. Hampl M, Wentzensen N, Vinokurova S et al. Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile. J. Cancer Res. Clin. Oncol. 2007; 133; 235-245.
38. Hording U, Junge J, Daugaard S, Lundvall F, Poulsen H, Bock JE. Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol. Oncol. 1994; 52; 241-246.
39. de Bie RP, van de Nieuwenhof HP, Bekkers RL et al. Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities. Br. J. Cancer 2009; 101; 27-31.
40. Preti M, van Seters M, Sideri M, van Beurden M. Squamous vulvar intraepithelial neoplasia. Clin. Obstet. Gynecol. 2005; 48; 845-861.
41. Sykes P, Smith N, McCormick P, Frizelle FA. High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999. Aust. N. Z. J. Obstet. Gynaecol. 2002; 42; 69-74.
42. van de Nieuwenhof HP, Massuger LF, van der Avoort I et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur. J. Cancer 2009; 45; 851-856.
43. Saraiya M, Watson M, Wu X et al. Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer 2008; 10(Suppl.); 2865-2872.
44. Joura EA, Losch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J. Reprod. Med. 2000; 45; 613-615.
45. Heller DS, Van Seters M, Marchitelli C, Moyal-Barracco M, Preti M, van Beurden M. Update on intraepithelial neoplasia of the vulva: proceedings of a Workshop at the 2009 World Congress of the International Society for the Study of Vulvovaginal Diseases, Edinburgh, Scotland, September 2009. J. Low. Genit. Tract. Dis. 2010; 14; 363-373.
46. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J. Natl Cancer Inst. 2009; 101; 1120-1130.
47. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002; 359; 108-113.
48. Lillo FB. Human papillomavirus infection and its role in the genesis of dysplastic and neoplastic lesions of the squamous epithelia. New Microbiol. 2005; 28; 111-118.
49. Garland SM, Steben M, Sings HL et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J. Infect. Dis. 2009; 199; 805-814.
50. Herod JJ, Shafi MI, Rollason TP, Jordan JA, Luesley DM. Vulvar intraepithelial neoplasia with superficially invasive carcinoma of the vulva. Br. J. Obstet. Gynaecol. 1996; 103; 453-456.
51. Hoevenaars BM, van der Avoort I, de Wilde PC et al. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Int. J. Cancer 2008; 123; 2767-2773.
52. Bergeron C, Ordi J, Schmidt D, Trunk MJ, Keller T, Ridder R. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am. J. Clin. Pathol. 2010; 133; 395-406.
53. Chen H, Gonzalez JL, Brennick JB, Liu M, Yan S. Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A. Am. J. Surg. Pathol. 2010; 34; 1250-1257.
54. Badr RE, Walts AE, Chung F, Bose S. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am. J. Surg. Pathol. 2008; 32; 899-906.
55. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am. J. Surg. Pathol. 2000; 24; 429-441.
56. Mulvany NJ, Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int. J. Gynecol. Pathol. 2008; 27; 125-135.
57. Eva LJ, Ganesan R, Chan KK, Honest H, Luesley DM. Differentiated-type vulval intraepithelial neoplasia has a high-risk association with vulval squamous cell carcinoma. Int. J. Gynecol. Cancer 2009; 19; 741-744.
58. Pinto AP, Miron A, Yassin Y et al. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma. Mod. Pathol. 2010; 23; 404-412.
59. Rolfe KJ, MacLean AB, Crow JC, Benjamin E, Reid WM, Perrett CW. TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br. J. Cancer 2003; 89; 2249-2253.
60. Gambichler T, Kammann S, Tigges C et al. Cell cycle regulation and proliferation in lichen sclerosus. Regul. Pept. 2011; 167; 209-214.
61. Hantschmann P, Sterzer S, Jeschke U, Friese K. P53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus. Anticancer Res. 2005; 25; 1739-1745.
62. Santos M, Montagut C, Mellado B et al. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int. J. Gynecol. Pathol. 2004; 23; 206-214.
63. Ordi J, Alejo M, Fuste V et al. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. Am. J. Surg. Pathol. 2009; 33; 1659-1665.
64. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet. Gynecol. 2005; 106; 1319-1326.
65. Van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol. Oncol. 2005; 97; 645-651.
66. Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J. Low. Genit. Tract. Dis. 2006; 10; 161-169.
67. Jones RW, Rowan DM. Spontaneous regression of vulvar intraepithelial neoplasia 2-3. Obstet. Gynecol. 2000; 96; 470-472.
68. Stephenson RD, Denehy TR. Rapid spontaneous regression of acute-onset vulvar intraepithelial neoplasia 3 in young women: a case series. J. Low. Genit. Tract. Dis. 2012; 16; 56-58.
69. Heller DS, Cracchiolo B, Hameed M, May T. Pregnancy-associated invasive squamous cell carcinoma of the vulva in a 28-year-old, HIV-negative woman. A case report. J. Reprod. Med. 2000; 45; 659-661.
70. Eva LJ, Ganesan R, Chan KK, Honest H, Malik S, Luesley DM. Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur: a review of 154 cases. J. Reprod. Med. 2008; 53; 397-401.
71. Terlou A, Blok LJ, Helmerhorst TJ, van Beurden M. Premalignant epithelial disorders of the vulva: squamous vulvar intraepithelial neoplasia, vulvar Paget's disease and melanoma in situ. Acta Obstet. Gynecol. Scand. 2010; 89; 741-748.
72. Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res. 2001; 61; 192-196.
73. Jones RW. Vulval intraepithelial neoplasia: current perspectives. Eur. J. Gynaecol. Oncol. 2001; 22; 393-402.
74. Adamek K, Szczudrawa A, Basta A. Coexistence of VIN and vulvar invasive cancer with intraepithelial neoplasia and invasive carcinoma of the cervix and/or vagina, and HPV infection of the low female genital tract. Ginekol. Pol. 2003; 74; 657-661.
75. Goffin F, Mayrand MH, Gauthier P et al. High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. J. Med. Virol. 2006; 78; 814-819.
76. Lara-Torre E, Perlman SE. Vulvar intraepithelial neoplasia in adolescents with abnormal Pap smear results: a series report. J. Pediatr. Adolesc. Gynecol. 2004; 17; 45-48.
77. Feng Q, Kiviat NB. New and surprising insights into pathogenesis of multicentric squamous cancers in the female lower genital tract. J. Natl Cancer Inst. 2005; 97; 1798-1799.
78. Bekkers RL, Massuger LF, Bulten J, Melchers WJ. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev. Med. Virol. 2004; 14; 95-105.
79. McNally OM, Mulvany NJ, Pagano R, Quinn MA, Rome RM. VIN 3: a clinicopathologic review. Int. J. Gynecol. Cancer 2002; 12; 490-495.
80. Tavassoli FA, Devillee P. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003.
81. Kagie MJ, Kenter GG, Hermans J, Trimbos JB, Fleuren GJ. The relevance of various vulvar epithelial changes in the early detection of squamous cell carcinoma of the vulva. Int. J. Gynecol. Cancer 1997; 7; 50-57.
82. Horn LC, Liebert UG, Edelmann J, Hockel M, Einenkel J. Adenoid squamous carcinoma (pseudoangiosarcomatous carcinoma) of the vulva: a rare but highly aggressive variant of squamous cell carcinoma-report of a case and review of the literature. Int. J. Gynecol. Pathol. 2008; 27; 288-291.
83. Ambros RA, Malfetano JH, Mihm MC Jr. Clinicopathologic features of vulvar squamous cell carcinomas exhibiting prominent fibromyxoid stromal response. Int. J. Gynecol. Pathol. 1996; 15; 137-145.
84. del Pino M, Bleeker MC, Quint WG, Snijders PJ, Meijer CJ, Steenbergen RD. Comprehensive analysis of human papillomavirus prevalence and the potential role of low-risk types in verrucous carcinoma. Mod. Pathol. 2012; 25; 1354-1363.
85. Fuste V, del Pino M, Perez A et al. Primary squamous cell carcinoma of the vagina: human papillomavirus detection, p16(INK4A) overexpression and clinicopathological correlations. Histopathology 2010; 57; 907-916.
86. Alos L, Moyano S, Nadal A et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer 2009; 115; 2701-2709.
87. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J. Clin. Oncol. 2009; 27; 1992-1998.
88. Fakhry C, Westra WH, Li S et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst. 2008; 100; 261-269.
89. Li W, Thompson CH, O'Brien CJ et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int. J. Cancer 2003; 106; 553-558.
90. Knopp S, Nesland JM, Trope C, Holm R. p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma. Am. J. Clin. Pathol. 2006; 126; 266-276.
91. Tringler B, Grimm C, Dudek G et al. p16INK4a expression in invasive vulvar squamous cell carcinoma. Appl. Immunohistochem. Mol. Morphol. 2007; 15; 279-283.
92. Lindell G, Nasman A, Jonsson C et al. Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node. Gynecol. Oncol. 2010; 117; 312-316.
93. Ansink AC, Krul MR, De Weger RA et al. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. Gynecol. Oncol. 1994; 52; 180-184.
94. Kumar S, Shah JP, Bryant CS, Imudia AN, Morris RT, Malone JM Jr. A comparison of younger vs older women with vulvar cancer in the United States. Am. J. Obstet. Gynecol. 2009; 200; e52-e55.
95. Nuovo GJ, Delvenne P, MacConnell P, Chalas E, Neto C, Mann WJ. Correlation of histology and detection of human papillomavirus DNA in vulvar cancers. Gynecol. Oncol. 1991; 43; 275-280.
96. Choschzick M, Hantaredja W, Tennstedt P, Gieseking F, Wolber L, Simon R. Role of TP53 mutations in vulvar carcinomas. Int. J. Gynecol. Pathol. 2011; 30; 497-504.
97. Alonso I, Felix A, Torne A et al. Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina. Gynecol. Oncol. 2012; 125; 194-199.
98. Lerma E, Matias-Guiu X, Lee SJ, Prat J. Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb. Int. J. Gynecol. Pathol. 1999; 18; 191-197.
99. Ballouk F, Ambros RA, Malfetano JH, Ross JS. Evaluation of prognostic indicators in squamous carcinoma of the vulva including nuclear DNA content. Mod. Pathol. 1993; 6; 371-375.
100. Scheistroen M, Trope C, Pettersen EO, Nesland JM. p53 protein expression in squamous cell carcinoma of the vulva. Cancer 1999; 85; 1133-1138.
101. Emanuels AG, Koudstaal J, Burger MP, Hollema H. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases. Br. J. Cancer 1999; 80; 38-43.
102. Hantschmann P, Lampe B, Beysiegel S, Kurzl R. Tumor proliferation in squamous cell carcinoma of the vulva. Int. J. Gynecol. Pathol. 2000; 19; 361-368.
103. Rosenthal AN, Ryan A, Hopster D, Jacobs IJ. Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases. Int. J. Cancer 2002; 99; 549-554.
104. Ueda Y, Enomoto T, Miyatake T et al. Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of the vulvar mucosa. Am. J. Clin. Pathol. 2004; 122; 266-274.
105. Jin Z, Wallace L, Harper SQ, Yang J. PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development. J. Biol. Chem. 2010; 285; 34493-34502.
106. Vilmer C, Cavelier-Balloy B, Nogues C, Trassard M, Le Doussal V. Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases. Eur. J. Gynaecol. Oncol. 1998; 19; 25-31.
107. Rouzier R, Morice P, Haie-Meder C et al. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas. Gynecol. Oncol. 2001; 81; 414-419.
108. Smeets SJ, Hesselink AT, Speel EJ et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int. J. Cancer 2007; 121; 2465-2472.
109. Holway AH, Rieger-Christ KM, Miner WR et al. Somatic mutation of PTEN in vulvar cancer. Clin. Cancer Res. 2000; 6; 3228-3235.
110. van der Avoort IA, van de Nieuwenhof HP, Otte-Holler I et al. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva. Hum. Pathol. 2010; 41; 1475-1485.
111. Allen DG, Hutchins AM, Hammet F et al. Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers. Br. J. Cancer 2002; 86; 924-928.
112. Jee KJ, Kim YT, Kim KR, Kim HS, Yan A, Knuutila S. Loss in 3p and 4p and gain of 3q are concomitant aberrations in squamous cell carcinoma of the vulva. Mod. Pathol. 2001; 14; 377-381.
113. Guerrero D, Guarch R, Ojer A et al. Differential hypermethylation of genes in vulvar cancer and lichen sclerosus coexisting or not with vulvar cancer. Int. J. Cancer 2011; 128; 2853-2864.